Franklyn G Prendergast Eli Lilly & CO (LLY) insider trading activity

LLY Quotes by TradingView

Franklyn G Prendergast is Director of ELI LILLY & Co. Currently has a direct ownership of 68,574 shares of LLY, which is worth approximately $63.4 Million. The most recent transaction as insider was on Nov 20, 2017, when has been sold 802 shares (Common Stock) at a price of $83.18 per share, resulting in proceeds of $66,710. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.6K
0% 3M change
0% 12M change
Total Value Held $63.4 Million

FRANKLYN G PRENDERGAST Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2017
BUY
Grant, award, or other acquisition
$66,710 $83.18 p/Share
802 Added 1.16%
68,574 Common Stock

Also insider at

VYNT
Vyant Bio, Inc. Healthcare
Director
IMNM
Immunome Inc. Healthcare
Director
NBSE
NeuBase Therapeutics, Inc. Healthcare
Director
LTRN
Lantern Pharma Inc. Healthcare
Director
FGP

Franklyn G Prendergast

Director
Rutherford, NJ

Track Institutional and Insider Activities on LLY

Follow ELI LILLY & Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LLY shares.

Notify only if

Insider Trading

Get notified when an Eli Lilly & CO insider buys or sells LLY shares.

Notify only if

News

Receive news related to ELI LILLY & Co

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LLY